NASDAQ$EXAS
Exact Sciences Corp · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Exact Sciences announced first quarter 2020 results with revenue of $347.8 million.
Exact Sciences Corp. reported revenue of $347.8 million for the first quarter ended March 31, 2020, compared to $162.0 million for the same period of 2019. The company's screening revenue was $219.5 million, an increase of 35 percent, while precision oncology revenue was $128.4 million. The net loss was $105.7 million, or $0.71 per share.
- Total revenue was $347.8 million, compared to $162.0 million.
- Screening revenue was $219.5 million, an increase of 35 percent.
- Precision Oncology revenue was $128.4 million.
- Net loss was $105.7 million, or $0.71 per share.
Headline financials
Revenue & EPS history
Exact Sciences · Revenue · Quarterly
$348M
Revenue by segment
Exact Sciences · $348M total across 2 segments · Q1 2020
- Screening$220M+35.5%63.1%
- Precision Oncology$128M—36.9%
Forward guidance
Exact Sciences plans to play an even greater role in cancer screening and guiding therapy decisions after the coronavirus pandemic abates.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2020
+0.8%
Avg return
Earnings day
+2.3%
Avg return
5 days after
+3.4%
Avg return
30 days after
55%
35 / 64 earnings
Positive
+35.0%
Q2 2016
Best reaction
-27.1%
Q3 2010
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | — | — | — | |
| Q4 2025 | +0.0% | +0.0% | +0.7% | |
| Q3 2025 | +3.8% | -1.2% | +51.0% | |
| Q2 2025 | -8.2% | -11.0% | +14.7% | |
| Q1 2025 | +9.1% | +13.0% | +19.3% | |
| Q4 2024 | -1.9% | -0.6% | -9.6% | |
| Q3 2024 | -23.1% | -27.6% | -12.0% | |
| Q2 2024 | +24.3% | +19.7% | +32.4% | |
| Q1 2024 | -11.8% | -9.5% | -30.1% | |
| Q4 2023 | -5.2% | -8.3% | -1.0% | |
| Q3 2023 | +1.4% | +5.9% | +8.8% | |
| Q2 2023 | -12.7% | -12.6% | -14.2% | |
| Q1 2023 | +14.9% | +15.5% | +32.2% | |
| Q4 2022 | +1.9% | -5.4% | +3.0% | |
| Q3 2022 | +13.8% | +23.9% | +40.4% | |
| Q2 2022 | +0.8% | -0.3% | -23.2% | |
| Q1 2022 | -0.2% | -12.1% | -20.4% | |
| Q4 2021 | -6.9% | +5.7% | -9.5% | |
| Q3 2021 | -3.2% | +3.3% | -17.3% | |
| Q2 2021 | -0.0% | -3.2% | -7.2% | |
| Q1 2021 | -11.9% | -16.8% | -14.0% | |
| Q4 2020 | -9.0% | -4.6% | -17.4% | |
| Q3 2020 | +19.7% | +16.2% | +8.7% | |
| Q2 2020 | +0.1% | -1.8% | -22.7% | |
| Q1 2020 | +6.3% | +7.7% | +11.3% | |
| Q4 2019 | -1.1% | +1.4% | -46.8% | |
| Q3 2019 | -9.5% | -3.1% | -12.2% | |
| Q2 2019 | -0.0% | -2.4% | +1.9% | |
| Q1 2019 | -0.9% | +6.7% | +3.5% | |
| Q4 2018 | +10.1% | +10.7% | +6.4% | |
| Q3 2018 | +15.5% | +20.7% | +23.3% | |
| Q2 2018 | -11.7% | -12.9% | +28.1% | |
| Q1 2018 | +14.9% | +10.5% | +14.5% | |
| Q4 2017 | -9.2% | -4.9% | -5.4% | |
| Q3 2017 | +7.5% | +10.8% | +13.0% | |
| Q2 2017 | +0.5% | +0.1% | +4.2% | |
| Q1 2017 | +26.1% | +30.1% | +40.0% | |
| Q4 2016 | +14.0% | +7.6% | +2.9% | |
| Q3 2016 | -22.1% | -20.5% | -19.3% | |
| Q2 2016 | +35.0% | +39.5% | +52.9% | |
| Q1 2016 | -16.9% | — | — | |
| Q4 2015 | -9.5% | — | — | |
| Q3 2015 | +1.0% | — | — | |
| Q2 2015 | -8.9% | — | — | |
| Q1 2015 | +6.2% | — | — | |
| Q4 2014 | -0.8% | — | — | |
| Q3 2014 | +6.1% | — | — | |
| Q2 2014 | +1.1% | — | — | |
| Q1 2014 | +0.7% | — | — | |
| Q4 2013 | +10.5% | — | — | |
| Q3 2013 | -1.0% | — | — | |
| Q2 2013 | -8.0% | — | — | |
| Q1 2013 | +2.4% | — | — | |
| Q4 2012 | +2.7% | — | — | |
| Q3 2012 | +5.4% | — | — | |
| Q2 2012 | +5.4% | — | — | |
| Q1 2012 | +1.4% | — | — | |
| Q4 2011 | +4.6% | — | — | |
| Q3 2011 | -4.1% | — | — | |
| Q2 2011 | -6.7% | — | — | |
| Q1 2011 | +1.6% | — | — | |
| Q4 2010 | +2.8% | — | — | |
| Q3 2010 | -27.1% | — | — | |
| Q2 2010 | +3.3% | — | — | |
| Q1 2010 | +6.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro